Premium
P3‐405: DOSE SELECTION FOR POTENTIAL COGNITIVE ENHANCING AGENT (ELND005, SCYLLO‐INOSITOL) IN ADULTS WITH DOWN SYNDROME WITHOUT DEMENTIA: UTILITY OF BIOMARKER‐BASED MODELING AND SIMULATION
Author(s) -
Liang Earvin,
Kesslak Patrick,
Kurth Matthias,
Bairu Menghis,
Abushakra Susan R.
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1500
Subject(s) - medicine , dementia , biomarker , pharmacodynamics , population , pharmacokinetics , oncology , dosing , cognition , placebo , disease , pharmacology , psychiatry , pathology , biochemistry , chemistry , alternative medicine , environmental health